This table provides the user to access information according to the inducer used to induce expression of fragile sites.
|
Fragile site inducer | No. of entries | Fragile sites | No. of fragile sites |
Aphidicolin | 2963 | FRA1A, FRA1B, FRA1C, FRA1D, FRA1E, FRA1F, FRA1G, FRA1I, FRA1K, FRA1L, FRA2C, FRA2D, FRA2E, FRA2F, FRA2G, FRA2H, FRA2I, FRA2J, FRA2S, FRA3A, FRA3B, FRA3C, FRA3D, FRA4A, FRA4C, FRA4D, FRA4E, FRA5C, FRA5D, FRA5E, FRA5F, FRA5H, FRA6B, FRA6C, FRA6E, FRA6F, FRA6G, FRA6H, FRA7B, FRA7C, FRA7D, FRA7E, FRA7F, FRA7G, FRA7H, FRA7I, FRA7J, FRA7K, FRA8B, FRA8C, FRA8D, FRA9D, FRA9E, FRA9G, FRA10D, FRA10E , FRA10F, FRA10G, FRA11C, FRA11D, FRA11E, FRA11F, FRA11G, FRA11H, FRA12B, FRA12E, FRA13A, FRA13C, FRA13D, FRA13E, FRA14B, FRA14C, FRA15A, FRA16C, FRA16D, FRA17B, FRA18A, FRA18B, FRA18C, FRA20B, FRA21A, FRA22B, FRAXB, FRAXC, FRAXD | 85 |
5-Azacytidine | 712 | FRA1H, FRA1J, FRA9F, FRA19A | 4 |
BrdU | 220 | FRA4B, FRA5A, FRA5B, FRA6D, FRA9C, FRA10B, FRA10C, FRA12C, FRA13B | 9 |
DistamycinA | 164 | FRA8E, FRA11I, FRA16B, FRA16E, FRA17A | 5 |
Folic Acid | 1118 | FRA1M, FRA2A, FRA2B, FRA2K, FRA2L, FRA5G, FRA6A, FRA7A, FRA8A, FRA9B, FRA10A, FRA11A, FRA11B, FRA12A, FRA12D, FRA16A, FRA19B, FRA20A, FRA22A, FRAXA, FRAXE, FRAXF | 22 |